Is Helicobacter pylori being treated appropriately? A study of inpatients and outpatients in a tertiary care centre

Canadian Journal of Gastroenterology

Volumn 21, Issue 5, 2007, Pages 285-288

  Nazareno, Jose ^a   Driman, David K ^a   Adams, Paul ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Helicobacter pylori; Inpatient; Outpatient; Treatment

Indexed keywords

ANTIINFECTIVE AGENT;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT; PATIENT SAFETY; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER; TERTIARY HEALTH CARE;

EID: 34250860157     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/628408     Document Type: Article

References (25)

1. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993;34:1672-6.
2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;16:1311-5.
3. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62. (Erratum in 1993;341:1668).
4. Parsonnet J, Hansen S, Rodriguez L, et ak. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
5. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
6. Soll AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 1996;275:622-9. (Erratum in 1996;275:1314).
7. Roll J, Weng A, Newman J. Diagnosis and treatment of Helicobacter pylori infection among California Medicare patients. Arch Intern Med 1997;157:994-8.
8. Thamer M, Ray NF, Henderson SC, Rinehart CS, Sherman CR, Ferguson JH. Influence of the NIH Consensus Conference on Helicobacter pylori on physician prescribing among a Medicaid population. Med Care 1998;36:646-60.
9. Gandhi TK. Fumbled handoffs: One dropped ball after another. Ann Intern Med 2005;142:352-8.
10. Haas JS, Cook EF, Puopolo A, Burstin HR, Brennan TA. Differences in the quality of care for women with an abnormal mammogram or breast complaint. J Gen Intern Med 2000;15:321-8.
11. Roy CL, Poon EG, Karson AS, et al. Patient safety concerns arising from test results that return after hospital discharge. Ann Intern Med 2005;143:121-8.
12. Cotton P. NIH consensus panel urges antimicrobials for ulcer patients, skeptics concur with caveats. JAMA 1994;271:808-9.
13. Hood HM, Wark C, Burgess PA, Nicewander D, Scott MW. Screening for Helicobacter pylori and nonsteroidal anti-inflammatory drug use in medicare patients hospitalized with peptic ulcer disease. Arch Intern Med 1999;159:149-54.
14. Shirin H, Birkenfeld S, Shevah O, et al. Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in Israel: Are we missing the malignant potential of Helicobacter pylori? J Clin Gastroenterol 2004;38:322-5.
15. Ilnyckyj A, Matthew G. Management of acute bleeding upper gastrointestinal ulcers in the era of endoscopic and intravenous proton pump inhibitor therapy. Can J Gastroenterol 2005;19:157-9.
16. Wong WM, Wong BC, Tang VS, et al. An evaluation of the PyloriTek test for the diagnosis of Helicobacter pylori infection in Chinese patients before and after eradication therapy. J Gastroenterol Hepatol 2001;16:976-80.
17. Viiala CH, Windsor HM, Forbes GM, Chairman SO, Marshall BJ, Mollison LC. Evaluation of a new formulation of CLOtest. J Gastroenterol Hepatol 2002;17:127-30.
18. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
19. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
20. George LL, Borody TJ, Andrews P, et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990;153:145-9.
21. Poon EG, Gandhi TK, Sequist TD, Murff HJ, Karson AS, Bates DW. "I wish I had seen this test result earlier!": Dissatisfaction with test result management systems in primary care. Arch Intern Med 2004; 164:2223-8.
22. Murff HJ, Gandhi TK, Karson AK, et al. Primary care physician attitudes concerning follow-up of abnormal test results and ambulatory decision support systems. Int J Med Inform 2003;71:137-49.
23. Glickman R. A 35-year-old man with epigastric pain. JAMA 1995;274:495-500.
24. Laine L. The long-term management of patients with bleeding ulcers: Helicobacter pylori eradication instead of maintenance antisecretory therapy. Gastrointest Endosc 1995;41:77-9.
25. Greenberg PD, Koch J, Cello JP. Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers. Am J Gastroenterol 1996;91:228-32.